Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hester Biosciences is a leading Indian animal healthcare company specializing in the development and manufacture of veterinary vaccines and health products. As the second-largest poultry vaccine manufacturer in India, the company produces a wide range of biologics for livestock and poultry, including its proprietary brands Reimmugen (Lumpy Skin Disease vaccine) and Suved (Sheep Pox vaccine). Hester operates state-of-the-art GMP manufacturing facilities in India, Nepal, and Tanzania, serving global markets with a focus on infectious disease prevention in animals. The company is publicly traded on the National Stock Exchange of India and continues to expand its portfolio into animal diagnostics and herbal health products. Hester plays a critical role in global animal health initiatives, collaborating with organizations like the Bill & Melinda Gates Foundation to eradicate diseases such as PPR.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suved and Reimmugen proprietary manufacturers.